QNTM
QNTM clinical trials: Quantum Biopharma Ltd.
Every trial on ClinicalTrials.gov where Quantum Biopharma Ltd. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
QNTM on the catalyst calendar · QNTM registry changes
- Primary completion May 24, 2023ActualPhase 2NCT05652907Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)Quantum Biopharma · Mast Cell Activation SyndromeTerminatedQNTMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 7, 2024ActualNo phase registeredNCT06505239Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol IntoxicationQuantum Biopharma · Acute Alcohol IntoxicationCompletedQNTMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 29, 2023ActualPhase 1NCT05821387Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy VolunteersQuantum Biopharma · Healthy ParticipantsCompletedQNTMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 24, 2021ActualPhase 2NCT04619706Ultramicronized Palmitoylethanolamide (PEA) Treatment in Hospitalized Participants With COVID-19Quantum Biopharma · COVID-19TerminatedQNTMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner